Anti-CNMD/ BRICD3/ CHM-I functional antibody

Anti-CNMD/ BRICD3/ CHM-I functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CNMD/CNMD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0305-Ab-1/ GM-Tg-hg-SE0305-Ab-2Anti-Human CNMD monoclonal antibodyHuman
GM-Tg-rg-SE0305-Ab-1/ GM-Tg-rg-SE0305-Ab-2Anti-Rat CNMD monoclonal antibodyRat
GM-Tg-mg-SE0305-Ab-1/ GM-Tg-mg-SE0305-Ab-2Anti-Mouse CNMD monoclonal antibodyMouse
GM-Tg-cynog-SE0305-Ab-1/ GM-Tg-cynog-SE0305-Ab-2Anti-Cynomolgus/ Rhesus macaque CNMD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0305-Ab-1/ GM-Tg-felg-SE0305-Ab-2Anti-Feline CNMD monoclonal antibodyFeline
GM-Tg-cang-SE0305-Ab-1/ GM-Tg-cang-SE0305-Ab-2Anti-Canine CNMD monoclonal antibodyCanine
GM-Tg-bovg-SE0305-Ab-1/ GM-Tg-bovg-SE0305-Ab-2Anti-Bovine CNMD monoclonal antibodyBovine
GM-Tg-equg-SE0305-Ab-1/ GM-Tg-equg-SE0305-Ab-2Anti-Equine CNMD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0305-Ab-1/ GM-Tg-hg-SE0305-Ab-2; GM-Tg-rg-SE0305-Ab-1/ GM-Tg-rg-SE0305-Ab-2;
GM-Tg-mg-SE0305-Ab-1/ GM-Tg-mg-SE0305-Ab-2; GM-Tg-cynog-SE0305-Ab-1/ GM-Tg-cynog-SE0305-Ab-2;
GM-Tg-felg-SE0305-Ab-1/ GM-Tg-felg-SE0305-Ab-2; GM-Tg-cang-SE0305-Ab-1/ GM-Tg-cang-SE0305-Ab-2;
GM-Tg-bovg-SE0305-Ab-1/ GM-Tg-bovg-SE0305-Ab-2; GM-Tg-equg-SE0305-Ab-1/ GM-Tg-equg-SE0305-Ab-2
Products NameAnti-CNMD monoclonal antibody
Formatmab
Target NameCNMD
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CNMD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0305-Ag-1Recombinant multi-species CNMD/ BRICD3/ CHM-I protein


    Target information

    Target IDGM-SE0305
    Target NameCNMD
    Gene ID11061,16840,81512,694189,609613,101091335,281683,100051618
    Gene Symbol and SynonymsBRICD3,Chm-1,CHM-I,CHM1,Chmd,CNMD,LECT1,MYETS1
    Uniprot AccessionO75829,O70367,P17404
    Uniprot Entry NameCNMD_HUMAN,CNMD_RAT,CNMD_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136110
    Target ClassificationN/A

    The target: CNMD, gene name: CNMD, also named as BRICD3, CHM-I, CHM1, LECT1, MYETS1. This gene encodes a glycosylated transmembrane protein that is cleaved to form a mature, secreted protein. The N-terminus of the precursor protein shares characteristics with other surfactant proteins and is sometimes called chondrosurfactant protein although no biological activity has yet been defined for it. The C-terminus of the precursor protein contains a 25 kDa mature protein called leukocyte cell-derived chemotaxin-1 or chondromodulin-1. The mature protein promotes chondrocyte growth and inhibits angiogenesis. This gene is expressed in the avascular zone of prehypertrophic cartilage and its expression decreases during chondrocyte hypertrophy and vascular invasion. The mature protein likely plays a role in endochondral bone development by permitting cartilaginous anlagen to be vascularized and replaced by bone. It may be involved also in the broad control of tissue vascularization during development. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.